Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030. (Record no. 19041208)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01997 a2200577 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515181553.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200910s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1528-4336 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1310/hct1003-143 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Wohl, D A |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20091015 |
| 245 00 - TITLE STATEMENT | |
| Title | Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | HIV clinical trials |
| Date of publication, distribution, etc. | |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 143-52 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | AIDS-Related Opportunistic Infections |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Acquired Immunodeficiency Syndrome |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antiretroviral Therapy, Highly Active |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antiviral Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | CD4 Lymphocyte Count |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cytomegalovirus |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cytomegalovirus Infections |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Double-Blind Method |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ganciclovir |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV Infections |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Polymerase Chain Reaction |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proportional Hazards Models |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Valganciclovir |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Viremia |
| General subdivision | drug therapy |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kendall, M A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Andersen, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Crumpacker, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Spector, S A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Feinberg, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Alston-Smith, B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Owens, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chafey, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Marco, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Maxwell, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lurain, N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jabs, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Benson, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Keiser, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jacobson, M A |
| 773 0# - HOST ITEM ENTRY | |
| Title | HIV clinical trials |
| Related parts | vol. 10 |
| -- | no. 3 |
| -- | p. 143-52 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1310/hct1003-143">https://doi.org/10.1310/hct1003-143</a> |
| Public note | Available from publisher's website |
No items available.